Mankind Pharma Limited has informed the Exchange regarding allotment of 38442 securities pursuant to ESOP/ESPS at its meeting held on November 19, 2026
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Mankind Pharma Limited has informed the Exchange regarding allotment of 38442 securities pursuant to ESOP/ESPS at its meeting held on November 19, 2026
Mankind Pharma Limited has informed the Exchange about General Updates
Mankind Pharma Limited has informed the Exchange about Schedule of meet
Mankind Pharma Limited has informed the Exchange about General Updates
Mankind Pharma Limited has informed the Exchange about Schedule of meet
Mankind Pharma Limited has informed the Exchange about Transcript
Mankind Pharma Limited has informed the Exchange about Credit Rating
Mankind Pharma Limited has informed the Exchange about Investor Presentation
Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication
Mankind Pharma Limited has informed the Exchange about Link of Recording
Mankind Pharma Limited has informed the Exchange about Investor Presentation
Mankind Pharma Limited has informed the Exchange about Investor Presentation
Mankind Pharma Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press Release on Financial Results for Q2 & H1 FY27".
Please find attached outcome of Board Meeting where Board has noted the merger of MCPPL & UAPL
Mankind Pharma Limited has informed the Exchange about Scheme of Arrangement
Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.